Two Sigma Advisers’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $493M | Buy |
|
|||||
|
2025
Q1 | $351M | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $946K | Sell |
|
|||||
|
2024
Q2 | $1.05M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $11.3M | Sell |
|
|||||
|
2023
Q3 | $200M | Sell |
|
|||||
|
2023
Q2 | $215M | Buy |
|
|||||
|
2023
Q1 | $172M | Buy |
|
|||||
|
2022
Q4 | $35M | Sell |
|
|||||
|
2022
Q3 | $79.8M | Sell |
|
|||||
|
2022
Q2 | $165M | Sell |
|
|||||
|
2022
Q1 | $342M | Buy |
|
|||||
|
2021
Q4 | $245M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $29.6M | Sell |
|
|||||
|
2020
Q2 | $76M | Buy |
|
|||||
|
2020
Q1 | $24.2M | Buy |
|
|||||
|
2019
Q4 | $14.7M | Sell |
|
|||||
|
2019
Q3 | $78.6M | Buy |
|
|||||
|
2019
Q2 | $75.4M | Sell |
|
|||||
|
2019
Q1 | $120M | Sell |
|
|||||
|
2018
Q4 | $213M | Sell |
|
|||||
|
2018
Q3 | $249M | Sell |
|
|||||
|
2018
Q2 | $255M | Buy |
|
|||||
|
2018
Q1 | $241M | Buy |
|
|||||
|
2017
Q4 | $143M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $1.27M | Sell |
|
|||||
|
2017
Q1 | $72.9M | Sell |
|
|||||
|
2016
Q4 | $76.3M | Sell |
|
|||||
|
2016
Q3 | $107M | Sell |
|
|||||
|
2016
Q2 | $135M | Sell |
|
|||||
|
2016
Q1 | $145M | Buy |
|
|||||
|
2015
Q4 | $138M | Buy |
|
|||||
|
2015
Q3 | $107M | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $217K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $3.42M | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $1.89M | Sell |
|
|||||
|
2013
Q4 | $2.42M | Sell |
|
|||||
|
2013
Q3 | $33.2M | Sell |
|
|||||
|
2013
Q2 | $42.4M | Buy |
|